MELINTA THERAPEUTICS, LLC
REZZAYO
Manufacturer:
MELINTA THERAPEUTICS, LLC
Name:
REZZAYO
HCPCS Code Descriptor:
Injection, rezafungin, 1 mg
Category:
J Code
HCPCS:
J0349
NDC(s):
70842-0240-01
Primary Type:
Anti-Fungal
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
REZZAYO is an Anti-Fungal drug manufactured by Melinta and administered via the intravenous route of administration. The J Code: J0349 is aligned to the drug REZZAYO.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/23
HCPCS Effective Date:
10/1/23
HCPCS Short Description:
Inj, rezafungin, 1 mg
Billing and Coding Guide:
https://www.rezzayo.com/wp-content/uploads/2023/07/Approved-PP-REZ-US-0129-Digital-Billing-and-Coding-Guide-for-REZZAYO-1.pdf
Patient Assistance:
https://www.rezzayo.com/support-and-resources/